Cooper Companies Inc., The (COO)

$99.91

+0.83

(+0.84%)▲

Market is closed - opens 8 PM, 22 Nov 2024

Performance

  • $98.27
    $100.02
    $99.91
    downward going graph

    1.64%

    Downside

    Day's Volatility :1.75%

    Upside

    0.11%

    downward going graph
  • $82.22
    $112.38
    $99.91
    downward going graph

    17.71%

    Downside

    52 Weeks Volatility :26.84%

    Upside

    11.09%

    downward going graph

Returns

PeriodCooper Companies Inc., TheSector (Health Care)Index (Russel 2000)
3 Months
6.16%
-6.9%
0.0%
6 Months
3.43%
-1.7%
0.0%
1 Year
17.87%
10.4%
0.0%
3 Years
-0.8%
8.8%
-24.1%

Highlights

Market Capitalization
19.7B
Book Value
$39.80
Earnings Per Share (EPS)
1.79
PE Ratio
55.35
PEG Ratio
10.03
Wall Street Target Price
114.294
Profit Margin
9.45%
Operating Margin TTM
19.2%
Return On Assets TTM
3.39%
Return On Equity TTM
4.65%
Revenue TTM
3.8B
Revenue Per Share TTM
19.14
Quarterly Revenue Growth YOY
7.8%
Gross Profit TTM
2.4B
EBITDA
1.0B
Diluted Eps TTM
1.79
Quarterly Earnings Growth YOY
0.21
EPS Estimate Current Year
3.65
EPS Estimate Next Year
4.07
EPS Estimate Current Quarter
0.91
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    54%Buy
    45%Hold
    0
    0%Sell
Based on 24 Wall street analysts offering stock ratings for Cooper Companies Inc., The(by analysts ranked 0 to 5 stars)
Based on 24 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
13
11
Hold
11
11
12
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 14.4%

Current $99.91
Target $114.29

Company Financials

FY18Y/Y Change
Revenue
2.5B
↑ 18.41%
Net Income
139.9M
↓ 62.48%
Net Profit Margin
5.52%
↓ 11.91%
FY19Y/Y Change
Revenue
2.7B
↑ 4.76%
Net Income
466.7M
↑ 233.6%
Net Profit Margin
17.59%
↑ 12.07%
FY20Y/Y Change
Revenue
2.4B
↓ 8.39%
Net Income
238.4M
↓ 48.92%
Net Profit Margin
9.81%
↓ 7.78%
FY21Y/Y Change
Revenue
2.9B
↑ 20.22%
Net Income
2.9B
↑ 1135.19%
Net Profit Margin
100.76%
↑ 90.95%
FY22Y/Y Change
Revenue
3.3B
↑ 13.2%
Net Income
385.8M
↓ 86.9%
Net Profit Margin
11.66%
↓ 89.1%
FY23Y/Y Change
Revenue
3.6B
↑ 8.61%
Net Income
294.2M
↓ 23.74%
Net Profit Margin
8.19%
↓ 3.47%
Q2 FY23Q/Q Change
Revenue
877.4M
↑ 2.2%
Net Income
39.8M
↓ 52.96%
Net Profit Margin
4.54%
↓ 5.31%
Q3 FY23Q/Q Change
Revenue
930.2M
↑ 6.02%
Net Income
85.3M
↑ 114.32%
Net Profit Margin
9.17%
↑ 4.63%
Q4 FY23Q/Q Change
Revenue
927.1M
↓ 0.33%
Net Income
84.5M
↓ 0.94%
Net Profit Margin
9.11%
↓ 0.06%
Q1 FY24Q/Q Change
Revenue
931.6M
↑ 0.49%
Net Income
81.2M
↓ 3.91%
Net Profit Margin
8.72%
↓ 0.39%
Q2 FY24Q/Q Change
Revenue
942.6M
↑ 1.18%
Net Income
88.9M
↑ 9.48%
Net Profit Margin
9.43%
↑ 0.71%
Q3 FY24Q/Q Change
Revenue
1.0B
↑ 6.39%
Net Income
104.7M
↑ 17.77%
Net Profit Margin
10.44%
↑ 1.01%
FY18Y/Y Change
Total Assets
6.1B
↑ 25.81%
Total Liabilities
2.8B
↑ 66.68%
FY19Y/Y Change
Total Assets
6.3B
↑ 2.65%
Total Liabilities
2.6B
↓ 5.67%
FY20Y/Y Change
Total Assets
6.7B
↑ 7.38%
Total Liabilities
2.9B
↑ 10.08%
FY21Y/Y Change
Total Assets
9.6B
↑ 42.58%
Total Liabilities
2.7B
↓ 8.53%
FY22Y/Y Change
Total Assets
11.5B
↑ 19.63%
Total Liabilities
4.3B
↑ 62.06%
FY23Y/Y Change
Total Assets
11.7B
↑ 1.45%
Total Liabilities
4.1B
↓ 4.86%
Q2 FY23Q/Q Change
Total Assets
11.5B
↓ 0.19%
Total Liabilities
4.2B
↓ 1.51%
Q3 FY23Q/Q Change
Total Assets
11.7B
↑ 1.37%
Total Liabilities
4.2B
↑ 0.18%
Q4 FY23Q/Q Change
Total Assets
11.7B
↓ 0.33%
Total Liabilities
4.1B
↓ 1.46%
Q1 FY24Q/Q Change
Total Assets
12.0B
↑ 3.21%
Total Liabilities
4.3B
↑ 5.58%
Q2 FY24Q/Q Change
Total Assets
12.0B
↑ 0.12%
Total Liabilities
4.2B
↓ 2.16%
Q3 FY24Q/Q Change
Total Assets
12.1B
↑ 0.5%
Total Liabilities
4.2B
↓ 1.43%
FY18Y/Y Change
Operating Cash Flow
668.9M
↑ 12.69%
Investing Cash Flow
-1.5B
↑ 297.98%
Financing Cash Flow
844.4M
↓ 470.51%
FY19Y/Y Change
Operating Cash Flow
713.2M
↑ 6.62%
Investing Cash Flow
-351.3M
↓ 76.85%
Financing Cash Flow
-351.4M
↓ 141.62%
FY20Y/Y Change
Operating Cash Flow
486.6M
↓ 31.77%
Investing Cash Flow
-364.5M
↑ 3.76%
Financing Cash Flow
-95.5M
↓ 72.82%
FY21Y/Y Change
Operating Cash Flow
738.6M
↑ 51.79%
Investing Cash Flow
-450.3M
↑ 23.54%
Financing Cash Flow
-311.4M
↑ 226.07%
FY22Y/Y Change
Operating Cash Flow
692.4M
↓ 6.26%
Investing Cash Flow
-1.8B
↑ 306.66%
Financing Cash Flow
1.2B
↓ 483.33%
FY23Y/Y Change
Operating Cash Flow
607.5M
↓ 12.26%
Investing Cash Flow
-449.0M
↓ 75.48%
Financing Cash Flow
-173.9M
↓ 114.57%
Q2 FY23Q/Q Change
Operating Cash Flow
124.2M
↓ 25.45%
Investing Cash Flow
-82.0M
↓ 27.63%
Financing Cash Flow
-46.8M
↓ 39.69%
Q3 FY23Q/Q Change
Operating Cash Flow
142.5M
↑ 14.73%
Investing Cash Flow
-288.2M
↑ 251.46%
Financing Cash Flow
-43.0M
↓ 8.12%
Q4 FY23Q/Q Change
Operating Cash Flow
174.2M
↑ 22.25%
Investing Cash Flow
-160.8M
↓ 44.21%
Financing Cash Flow
-6.5M
↓ 84.88%

Technicals Summary

Sell

Neutral

Buy

Cooper Companies Inc., The is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cooper Companies Inc., The
Cooper Companies Inc., The
-5.59%
3.43%
17.87%
-0.8%
29.83%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
6.4%
37.35%
74.36%
61.6%
190.06%
Resmed Inc.
Resmed Inc.
1.51%
11.6%
59.62%
-5.3%
67.71%
Becton, Dickinson And Company
Becton, Dickinson And Company
-5.95%
-3.84%
-4.79%
-8.09%
-9.78%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
12.04%
-4.01%
-8.63%
-26.69%
119.18%
Alcon Ag
Alcon Ag
-9.58%
-5.71%
17.48%
6.3%
50.86%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cooper Companies Inc., The
Cooper Companies Inc., The
55.35
55.35
10.03
3.65
0.05
0.03
NA
39.8
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
86.97
86.97
4.02
6.85
0.16
0.08
NA
43.75
Resmed Inc.
Resmed Inc.
32.04
32.04
1.83
7.71
0.24
0.13
0.01
35.39
Becton, Dickinson And Company
Becton, Dickinson And Company
37.57
37.57
1.03
13.11
0.06
0.03
0.02
89.5
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
46.31
46.31
5.82
6.66
0.18
0.1
0.0
37.96
Alcon Ag
Alcon Ag
36.54
36.54
3.09
3.03
0.06
0.03
0.0
43.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cooper Companies Inc., The
Cooper Companies Inc., The
Buy
$19.7B
29.83%
55.35
9.45%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$193.0B
190.06%
86.97
28.51%
Resmed Inc.
Resmed Inc.
Buy
$35.5B
67.71%
32.04
23.15%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$64.3B
-9.78%
37.57
7.13%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$22.6B
119.18%
46.31
17.37%
Alcon Ag
Alcon Ag
Buy
$42.3B
50.86%
36.54
11.89%

Insights on Cooper Companies Inc., The

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 927.1M → 1.00B (in $), with an average increase of 2.6% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, 81.2M → 104.7M (in $), with an average increase of 11.9% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 74.4% return, outperforming this stock by 56.5%

  • Vs ISRG

    In the last 3 years, Intuitive Surgical, Inc. has given 61.6% return, outperforming this stock by 62.4%

Institutional Holdings

  • Vanguard Group Inc

    12.00%

  • BlackRock Inc

    8.74%

  • State Street Corp

    4.26%

  • Kayne Anderson Rudnick Investment Management LLC

    3.93%

  • T. Rowe Price Investment Management,Inc.

    3.78%

  • AllianceBernstein L.P.

    2.65%

Corporate Announcements

  • Cooper Companies Inc., The Dividends March,2023

    In the quarter ending March,2023. Cooper Companies Inc., The has declared dividend of $0.03

    Read More

Company Information

company overview the cooper companies, inc. ("cooper"​) is a global medical device company publicly traded on the nyse euronext (nyse:coo). cooper is dedicated to being a quality of life company™ with a focus on delivering shareholder value. cooper operates through two business units, coopervision and coopersurgical. coopervision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. coopersurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. headquartered in pleasanton, ca, cooper has approximately 9,000 employees with products sold in over 100 countries. for more information, please visit www.coopercos.com.

Organization
Cooper Companies Inc., The
Employees
15000
CEO
Mr. Albert G. White III
Industry
Health Technology

FAQs